Funding Rounds
Orikine Bio

Orikine Bio Seed (2023, $6M)

Orikine Bio

Novel proprietary platform for cytokine-based therapies.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $6.20M

Investors